Clinical Trial Highlights

• Results from the STICH Trial
• Relaxin Reduces Dyspnea, Cardiovascular Death, and Rehospitalization in Acute Heart Failure
• JUPITER Study Continues to Make News
• Patients Receiving Hemodialysis for Treatment of End-Stage Renal Disease Did Not Benefit from Statin Therapy: Results of the AURORA Trial
• Polypill May Offer Increased Protection against Cardiovascular Disease in Patients with Average Risk Factors
• No Benefit from Omega-3 Supplements in Addition to Optimal Medical Therapy
• Early Routine Eptifibatide Use is Not Superior to Delayed Provisional Use in NSTE ACS
• Genetic Variants Associated with Early Onset Myocardial Infarction also Associated with Need for Future Revascularization
• Emerging Technologies to Treat Heart Disease
• Novel Interventional Approaches are Effective against Resistant Hypertension
• Clopidogrel Added to Aspirin Reduces Stroke Risk in Atrial Fibrillation Patients Unsuitable for Vitamin K Antagonist Therapy
• Adding Cardiac Resynchronization Therapy (CRT) May Prevent Disease Progression in Asymptomatic and Mildly Symptomatic Heart Failure (HF) Patients Already on OMT